Specific Diagnostics Announces the Appointment of Scott Wehage as Director of US Clinical Trials
Share Article
Specific Diagnostics today announced the appointment of Scott Wehage as Director of US Clinical Trials. Previously Mr. Wehage was a Clinical Project Manager for Becton Dickinson’s Global Clinical Develop Department, where he oversaw clinical trials for device and IVD product development. Mr. Wehage will oversee the implementation of Specific’s expanding clinical studies strategy in the US.
Specific Diagnostics Patented Sensor Panel
“I’m truly looking forward to working with all of the distinguished KOL sites we are contracting with for our US clinical trials,” said Mr. Wehage. “Once FDA approved, I believe the Reveal will truly change the way US hospital systems manage and treat blood stream infections.”